Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth
Open Access
- 23 October 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 17 (5), 325-333
- https://doi.org/10.1038/cgt.2009.75
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- 14-3-3σ Modulates Pancreatic Cancer Cell Survival and InvasivenessClinical Cancer Research, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Pancreatic cancer–associated stroma productionThe American Journal of Surgery, 2007
- Cyclin D1 Functions in Cell MigrationCell Cycle, 2006
- Cytotoxic Chemotherapy for Pancreatic CancerDrugs, 2006
- Vascular Endothelial Growth Factor-Trap Suppresses Tumorigenicity of Multiple Pancreatic Cancer Cell LinesClinical Cancer Research, 2004
- Cyclin D1Governs Adhesion and Motility of MacrophagesMolecular Biology of the Cell, 2003
- A Short Primer on RNAiCell, 2001
- The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancerOncogene, 1999
- Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.JCI Insight, 1998